The Synthetic Biology Innovation Network

Editors' picks

New cell-free expression system runs on linear DNA

Before synthetic biology can retool the economy, save the planet, or help put people on Mars, it’s going to have to become significantly easier to use. Take computers. If you wanted to do anything useful with a computer...

How sweet it is: The next generation of natural, zero-calorie sweeteners

The future of DNA synthesis

DNA is the blueprint of life, as well as the cornerstone of the synthetic biology industry — the core of the design-build-test cycle that makes custom organisms and the things they produce. So it’s fitting that...

These 98 synthetic biology companies raised $3.8 billion in 2018

CRISPR is stuck, and this company can fix it

Zymergen raises $400M+ to deliver AI-enabled biology to global bio-based industry

Zymergen announced a $400+ million Series C funding round in support of its proprietary technology platform to produce novel and improved molecules to meet global-scale industrial needs. The majority of products used...

Here are 2018’s top articles on SynBioBeta

Four synthetic biology startups to watch in 2019

The bioeconomy is growing at an impressive rate, and doesn’t show signs of slowing. In 2017, 2016 was the year to beat. No problem — the bar was easily set higher than ever, and the community excitedly looked...

The Ladder of Proof: How VCs see your startup

How to win in the bioeconomy: A peek at Rob Carlson’s playbook

View all posts

Press releases

Evonetix appoints Stephanie Brooking as Head of Product Management

CAMBRIDGE, UK, 14 January 2019 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, today announced it has appointed Stephanie Brooking...

Precision BioSciences Announces Formation of Scientific Advisory Board With Anderson, Kantarjian, Schinazi and Turtle

DURHAM, North Carolina, USA, January 16, 2019 – Precision BioSciences today announced the formation of its Scientific Advisory Board (SAB) with four key appointments: Kenneth C. Anderson, MD, Hagop Kantarjian, MD...

eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive Officer

CAMBRIDGE, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) — eGenesis, a biotechnology company revolutionizing the field of transplantation with its multiplexed gene editing platform, today announced the appointment of Paul...

Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing

Rehovot, Israel & Cambé, Brazil– December 18, 2018 – Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets & TMG – Tropical Melhoramento &...

Genomatica Produces The First 600 Tons of Brontide Natural Butylene Glycol

Daicel, Azelis, Viachem equipped to service rising demand from hundreds of personal care formulators San Diego, California (January 15, 2019) – Genomatica, a widely-recognized technology leader for bio-based chemicals...

Arbor Biosciences and the IWGSC Partner on Wheat Exome

Arbor Biosciences, a worldwide leader in next generation sequencing (NGS) target enrichment and synthetic biology, announces their partnership with the International Wheat Genome Sequencing Consortium (IWGSC), an...

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This...

Inovio’s DNA-Encoded Monoclonal Antibody (dMAb™) Platform Leaps Forward with First-in-Human Trial

PLYMOUTH MEETING, Pa., Jan. 7, 2019 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) in collaboration with The Wistar Institute and the University of Pennsylvania announced today the initiation of the...

AbSci Establishes New Collaboration with Sanofi

AbSci and Sanofi entered into a collaboration to improve the manufacturability for two of Sanofi’s biotherapeutics VANCOUVER, Wash., Jan. 9, 2019 /PRNewswire/ — AbSci, a global leader in biotherapeutic...

Asimov Appoints Synthetic Biology Pioneer James J. Collins as Inaugural Member of Scientific Advisory Board

Dr. Collins brings multi-disciplinary expertise in the design and construction of synthetic gene circuits and programmable cells Cambridge, MA – January 11, 2019. Asimov, the synthetic biology company building a...

GreenLight Biosciences Announces $50 Million Funding Round

– Unique Cell-Free Bioproduction Platform delivers cost effective, high quality RNA solutions to human, animal and crop challenges. – Round will fund the expansion of discovery, development and commercial...

Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases

CAMBRIDGE, Mass. — January 7, 2019 — Sigilon Therapeutics, a biopharmaceutical company that discovers and develops Shielded Living Therapeutics, and the Massachusetts Institute of Technology today announced a strategic...